Home
Saturn V Capital Management reported a 4.7% stake in Monopar Therapeutics MNPR · 313,384 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.7%
- Last report
- 5.2% · filed 26/05/15
- Shares held
- 313,384 sh
- Class
- Common Stock, $0.001 par value
- Event date
- 26/06/30
- Filed
- 26/08/12
4.7% stake · below 5%
- Stake
- 4.7%
- Last report
- 5.2%
- Since last report
- −0.5pp
Monopar Therapeutics trades, last 26 weeks
What else happened in Monopar Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Saturn V Capital Management's other 5% stake reports
- Saturn V Capital Management
5% stakeMonopar Therapeutics
5% stakeMonopar Therapeutics
MNPR
5.2% stake
345,626 sh
5.2% stake
Filed 05/15
- Saturn V Capital Management
5% stakeImmix Biopharma
5% stakeImmix Biopharma
IMMX
6.97% stake
3,693,585 sh
6.97% stake
Filed 02/17
- Saturn V Capital Management
5% stakeX4 Pharmaceuticals
5% stakeX4 Pharmaceuticals
XFOR
7.36% stake
6,433,481 sh
7.36% stake
Filed 02/17
